Immunotherapy for glioma: Current management and future application

Gliomas are intrinsic brain tumors that originate from neuroglial progenitor cells. Conventional therapies, including surgery, chemotherapy, and radiotherapy, have achieved limited improvements in the prognosis of glioma patients. Immunotherapy, a revolution in cancer treatment, has become a promisi...

Full description

Saved in:

Bibliographic Details
Published in:	Cancer letters Vol. 476; pp. 1 - 12
Main Authors:	Xu, Shengchao, Tang, Lu, Li, Xizhe, Fan, Fan, Liu, Zhixiong
Format:	Journal Article
Language:	English
Published:	Ireland Elsevier B.V 28.04.2020 Elsevier Limited
Subjects:	Antibodies Apoptosis Blood-brain barrier Brain cancer Brain Neoplasms - immunology Brain Neoplasms - pathology Brain Neoplasms - therapy Brain tumors Cancer therapies Central nervous system Checkpoint Chemotherapy Clinical trials Cytotoxicity Disease Management FDA approval Glioma Glioma - immunology Glioma - pathology Glioma - therapy Humans Immunotherapy Immunotherapy - methods Ligands Medical prognosis Medical research Melanoma Oncolytic virus Progenitor cells Prognosis Radiation therapy Stem cells Surgery Tumors Vaccine Vascular endothelial growth factor Checkpoint Vaccine Oncolytic virus Glioma Immunotherapy
ISSN:	0304-3835, 1872-7980, 1872-7980
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!